期刊文献+

同型半胱氨酸联合易栓三项对胎儿生长受限的预测价值 被引量:2

Predictive Value of Homocysteine Combined with Three Indicators of Thrombophilia for Fetal Growth Restriction
在线阅读 下载PDF
导出
摘要 目的:评估孕妇血清易栓三项[蛋白C(protein C,PC)、蛋白S(protein S,PS)、抗凝血酶Ⅲ(antithrombin-Ⅲ,AT-Ⅲ)]联合同型半胱氨酸(homocysteine,Hcy)对存在高危因素的孕妇发生胎儿生长受限(fetal growth restriction,FGR)的临床预测价值,为FGR早期诊治提供参考。方法:选择2018年9月-2020年3月于本院产科进行围产保健的存在FGR高危因素的孕妇120例为研究对象,所有孕妇于孕11~20周抽取静脉血检测PS、PC、AT-Ⅲ活性及Hcy水平,并随访至胎儿娩出,其中3例脱落,39例发生FGR者作为病例组,78例胎儿发育正常者为对照组。比较两组孕11~20周血清PC、PS、AT-Ⅲ及Hcy水平。采用多因素logistic回归分析确定FGR发生的独立危险因素,绘制受试者工作曲线(ROC),记录曲线下面积(AUC),分析PC、PS、AT-Ⅲ及Hcy预测FGR发生的临床价值。结果:病例组Hcy水平高于对照组,PC与AT-Ⅲ活性均低于对照组(P<0.05)。logistic回归分析结果显示,血清Hcy及AT-Ⅲ是FGR发生的独立危险因素(P<0.05)。ROC曲线分析表明,Hcy及AT-Ⅲ单独检测预测FGR的AUC分别为0.761、0.811,联合检测预测FGR的AUC为0.892。结论:血清Hcy及AT-Ⅲ是发生FGR的独立危险因素,两者联合检测对FGR预测价值较高。 Objective:To evaluate the clinical predictive value of maternal serum three indicators of thrombophilia[protein C(PC),protein S(PS),antithrombin-Ⅲ(AT-Ⅲ)]combined with homocysteine(Hcy)in the occurrence of fetal growth restriction(FGR)in pregnant women with high risk factors,so as to provide reference for the early diagnosis and treatment of FGR.Method:A total of 120 pregnant women with high risk factors for FGR who received perinatal health care in the obstetrics department of our hospital from September 2018 to March 2020 were selected as the research subjects.All pregnant women were sampled from 11 to 20 weeks of pregnancy to detect the activity of PS,PC,AT-Ⅲand Hcy level,and followed up until the delivery of the fetus,of which 3 cases fell out,and 39 cases with FGR were taken as the case group.78 cases of normal fetal development were the control group.The serum levels of PC,PS,AT-Ⅲand Hcy were compared between the two groups at 11 to 20 weeks of gestation.Multivariate logistic regression analysis was used to determine the independent risk factors for the occurrence of FGR.Receiver operating curve(ROC)was drawn and the area under the curve(AUC)was recorded.The clinical value of PC,PS,AT-Ⅲand Hcy in predicting the occurrence of FGR was analyzed.Result:The level of Hcy in the case group was higher than that in the control group,and the activities of PC and AT-Ⅲin the case group were lower than those in the control group(P<0.05).Logistic regression analysis showed that serum Hcy and AT-Ⅲwere independent risk factors for FGR(P<0.05).ROC curve analysis showed that the AUC of FGR predicted by Hcy and AT-Ⅲalone detection was 0.761 and 0.811,respectively,and the AUC of FGR predicted by combined detection was 0.892.Conclusion:Serum Hcy and AT-Ⅲare independent risk factors for the occurrence of FGR,and their combined detection is of high predictive value for FGR.
作者 韩宁 陈莹莹 赵娜 赵红阳 胡亚琪 魏团君 HAN Ning;CHEN Yingying;ZHAO Na;ZHAO Hongyang;HU Yaqi;WEI Tuanjun(The Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中国医学创新》 CAS 2021年第13期7-10,共4页 Medical Innovation of China
基金 河南省医学科技攻关项目(联合共建)(LHGJ20190364)。
关键词 胎儿生长受限 蛋白C 抗凝血酶Ⅲ 同型半胱氨酸 Fetal growth restriction Protein C Autoprothrombin-Ⅲ Homocysteine
作者简介 通信作者:韩宁。
  • 相关文献

参考文献7

二级参考文献77

  • 1王东辉,台桂香,王奭骥.妊娠女性外周血激活素A及卵泡休止素水平变化的关系[J].中国妇幼保健,2006,21(8):1101-1103. 被引量:3
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5249
  • 3颜耀华,李力,王云,陈志强,俞丽丽.胎盘生长因子于胎儿生长受限时在胎盘及蜕膜组织中的表达[J].第三军医大学学报,2007,29(3):203-206. 被引量:8
  • 4Mudd SH, Finkelstein JD, Refsum H, et al. Homocysteiue and its disulfide derivatives: a suggested consensus terminology [ J ]. Arterioscler Thromb Vasc Biol, 2000, 20 ( 7 ) : 1704-1706.
  • 5McCully KS. Vascular pathology of homocysteinemia : implications for the pathogenesis of arteriosclerosis [ J ]. Am J Pathol, 1969, 56(1) :111-128.
  • 6Soinio M, Marniemi J, Laakso M, et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus [ J ]. Ann Intern Med, 2004, 140(2) :94-100.
  • 7Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteiue and athemsclerotic peripheral vascular disease [ J ]. Ann Vasc Surg, 1997, 11(3):217-223.
  • 8Nyggtrd O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease[J]. N Engl J Med, 1997, 337(4) :230-236.
  • 9Perry IJ, Refsum H, Morris RW, et al. Prospective study ol serum total homoeysteine concentration and risk of stroke in middle-aged British men [ J]. Lancet, 1995, 346 ( 8987 ) : 1395- 1398.
  • 10Ranucei M, Ballotta A, Frigiola A, el al. Pre-operative homoeysteine levels and morbidity and mortality following cardiac surgery[ J]. Eur Heart J, 2009, 30(8) :995-1004.

共引文献83

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部